All-trans Retinoic Acid, and Arsenic +/- Idarubicin

Clinical trial NCT00413166 · COMPLETED

Trial details

NCT number: NCT00413166
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Promyelocytic Leukemia

Start date: 2006-12-01
Primary completion: 2016-02-01
Enrollment: 78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.